AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
ETHANOL INCREASES RISK OF ACETAMINOPHEN HEPATOTOXICITY IN HEALTHY-ADULTS
Authors: CHIEN JY THUMMEL KE SLATTERY JT RO H NELSON SD LOWN KS WATKINS PB
Citation: Jy. Chien et al., ETHANOL INCREASES RISK OF ACETAMINOPHEN HEPATOTOXICITY IN HEALTHY-ADULTS, Hepatology, 28(4), 1998, pp. 380-380
THERAPEUTIC MONITORING OF BUSULFAN IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: SLATTERY JT RISLER LJ
Citation: Jt. Slattery et Lj. Risler, THERAPEUTIC MONITORING OF BUSULFAN IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Therapeutic drug monitoring, 20(5), 1998, pp. 543-549
COMPARISON OF HUMAN LIVER AND SMALL-INTESTINAL GLUTATHIONE S-TRANSFERASE-CATALYZED BUSULFAN CONJUGATION IN-VITRO
Authors: GIBBS JP YANG JS SLATTERY JT
Citation: Jp. Gibbs et al., COMPARISON OF HUMAN LIVER AND SMALL-INTESTINAL GLUTATHIONE S-TRANSFERASE-CATALYZED BUSULFAN CONJUGATION IN-VITRO, Drug metabolism and disposition, 26(1), 1998, pp. 52-55
CYP3A4-MEDIATOD OXIDATION OF LISOFYLLINE TO LISOFYLLINE 4,5-DIOL IN HUMAN LIVER-MICROSOMES
Authors: SHIN HS SLATTERY JT
Citation: Hs. Shin et Jt. Slattery, CYP3A4-MEDIATOD OXIDATION OF LISOFYLLINE TO LISOFYLLINE 4,5-DIOL IN HUMAN LIVER-MICROSOMES, Journal of pharmaceutical sciences, 87(3), 1998, pp. 390-393
PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND ITS METABOLITES IN BONE-MARROW TRANSPLANTATION PATIENTS
Authors: REN S KALHORN TF MCDONALD GB ANASETTI C APPELBAUM FR SLATTERY JT
Citation: S. Ren et al., PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND ITS METABOLITES IN BONE-MARROW TRANSPLANTATION PATIENTS, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 289-301
HUMAN CD34(-TRANSFERASES-ALPHA() CELLS DO NOT EXPRESS GLUTATHIONE S)
Authors: CZERWINSKI M KIEM HP SLATTERY JT
Citation: M. Czerwinski et al., HUMAN CD34(-TRANSFERASES-ALPHA() CELLS DO NOT EXPRESS GLUTATHIONE S), Gene therapy, 4(3), 1997, pp. 268-270
CHARACTERIZATION OF CARBAMAZEPINE METABOLISM IN A MOUSE MODEL OF CARBAMAZEPINE TERATOGENICITY
Authors: AMORE BM KALHORN TF SKILES GL HUNTER AP BENNETT GD FINNELL RH NELSON SD SLATTERY JT
Citation: Bm. Amore et al., CHARACTERIZATION OF CARBAMAZEPINE METABOLISM IN A MOUSE MODEL OF CARBAMAZEPINE TERATOGENICITY, Drug metabolism and disposition, 25(8), 1997, pp. 953-962
CYTOCHROME-P450 ISOZYMES INVOLVED IN LISOFYLLINE METABOLISM TO PENTOXIFYLLINE IN HUMAN LIVER-MICROSOMES
Authors: LEE SH SLATTERY JT
Citation: Sh. Lee et Jt. Slattery, CYTOCHROME-P450 ISOZYMES INVOLVED IN LISOFYLLINE METABOLISM TO PENTOXIFYLLINE IN HUMAN LIVER-MICROSOMES, Drug metabolism and disposition, 25(12), 1997, pp. 1354-1358
MECHANISM OF CYTOCHROME-P450 ACTIVATION BY CAFFEINE AND 7,8-BENZOFLAVONE IN RAT-LIVER MICROSOMES
Authors: LEE CA MANYIKE PT THUMMEL KE NELSON SD SLATTERY JT
Citation: Ca. Lee et al., MECHANISM OF CYTOCHROME-P450 ACTIVATION BY CAFFEINE AND 7,8-BENZOFLAVONE IN RAT-LIVER MICROSOMES, Drug metabolism and disposition, 25(10), 1997, pp. 1150-1156
PHARMACOKINETIC CONSEQUENCES OF INDUCTION OF CYP2E1 BY LIGAND STABILIZATION
Authors: CHEN JY THUMMEL KE SLATTERY JT
Citation: Jy. Chen et al., PHARMACOKINETIC CONSEQUENCES OF INDUCTION OF CYP2E1 BY LIGAND STABILIZATION, Drug metabolism and disposition, 25(10), 1997, pp. 1165-1175
INFLUENCE OF POLYMORPHIC N-ACETYLTRANSFERASE PHENOTYPE ON THE INHIBITION AND INDUCTION OF ACETAMINOPHEN BIOACTIVATION WITH LONG-TERM ISONIAZID
Authors: CHIEN JT PETER RM NOLAN CM WARTELL C SLATTERY JT NELSON SD CARITHERS RL THUMMEL KE
Citation: Jt. Chien et al., INFLUENCE OF POLYMORPHIC N-ACETYLTRANSFERASE PHENOTYPE ON THE INHIBITION AND INDUCTION OF ACETAMINOPHEN BIOACTIVATION WITH LONG-TERM ISONIAZID, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 24-34
AGE-DEPENDENT TETRAHYDROTHIOPHENIUM ION FORMATION IN YOUNG-CHILDREN AND ADULTS RECEIVING HIGH-DOSE BUSULFAN
Authors: GIBBS JP MURRAY G RISLER L CHIEN JY DEV R SLATTERY JT
Citation: Jp. Gibbs et al., AGE-DEPENDENT TETRAHYDROTHIOPHENIUM ION FORMATION IN YOUNG-CHILDREN AND ADULTS RECEIVING HIGH-DOSE BUSULFAN, Cancer research, 57(24), 1997, pp. 5509-5516
OXIDATION OF CYCLOPHOSPHAMIDE TO 4-HYDROXYCYCLOPHOSPHAMIDE AND DESCHLOROETHYLCYCLOPHOSPHAMIDE IN HUMAN LIVER-MICROSOMES
Authors: REN S YANG JS KALHORN TF SLATTERY JT
Citation: S. Ren et al., OXIDATION OF CYCLOPHOSPHAMIDE TO 4-HYDROXYCYCLOPHOSPHAMIDE AND DESCHLOROETHYLCYCLOPHOSPHAMIDE IN HUMAN LIVER-MICROSOMES, Cancer research, 57(19), 1997, pp. 4229-4235
TARGET DOSE ADJUSTMENT OF BUSULFAN USING PHARMACOKINETIC PARAMETERS IN PEDIATRIC-PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION FOR MALIGNANCY OR INBORN-ERRORS
Authors: BOLINGER AM ZANGWILL AB SLATTERY JT DESANTES K HEYN L RISLER LJ MURRAY GL BOSTROM B COWAN MJ
Citation: Am. Bolinger et al., TARGET DOSE ADJUSTMENT OF BUSULFAN USING PHARMACOKINETIC PARAMETERS IN PEDIATRIC-PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION FOR MALIGNANCY OR INBORN-ERRORS, Blood, 90(10), 1997, pp. 1665-1665
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION
Authors: SLATTERY JT CLIFT RA BUCKNER CD RADICH J STORER B BENSINGER WI SOLL E ANASETTI C BOWDEN R BRYANT E CHAUNCEY T DEEG HJ DONEY KC FLOWERS M GOOLEY T HANSEN JA MARTIN PJ MCDONALD GB NASH R PETERSDORF EW SANDERS JE SCHOCH G STEWART P STORB R SULLIVAN KM THOMAS ED WITHERSPOON RP APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS
Authors: SLATTERY JT KALHORN TF MCDONALD GB LAMBERT K BUCKNER CD BENSINGER WI ANASETTI C APPELBAUM FR
Citation: Jt. Slattery et al., CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS, Journal of clinical oncology, 14(5), 1996, pp. 1484-1494
GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION INRELATION TO BUSULFAN PHARMACOKINETICS (VOL 16, PG 31, 1995)
Authors: SLATTERY JT SANDERS JE BUCKNER CD SCHAFFER RL LAMBERT KW LANGER FP ANASETTI C BENSINGER WI FISHER LD APPELBAUM FR HANSEN JA
Citation: Jt. Slattery et al., GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION INRELATION TO BUSULFAN PHARMACOKINETICS (VOL 16, PG 31, 1995), Bone marrow transplantation, 18(4), 1996, pp. 829-830
BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR AUTOLOGOUS OR SYNGENEIC MARROW TRANSPLANTATION FOR ACUTE AND CHRONICMYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS
Authors: DEMIRER T BUCKNER CD APPELBAUM FR BENSINGER WI SANDERS J LAMBERT K CLIFT R FEFER A STORB R SLATTERY JT
Citation: T. Demirer et al., BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR AUTOLOGOUS OR SYNGENEIC MARROW TRANSPLANTATION FOR ACUTE AND CHRONICMYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS, Bone marrow transplantation, 17(4), 1996, pp. 491-495
BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR ALLOGENEIC MARROW TRANSPLANTATION IN ADVANCED ACUTE AND CHRONIC MYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS
Authors: DEMIRER T BUCKNER CD APPELBAUM FR LAMBERT K BENSINGER WI CLIFT R STORB R SLATTERY JT
Citation: T. Demirer et al., BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR ALLOGENEIC MARROW TRANSPLANTATION IN ADVANCED ACUTE AND CHRONIC MYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS, Bone marrow transplantation, 17(3), 1996, pp. 341-346
BUSULFAN CONJUGATION BY GLUTATHIONE S-TRANSFERASE-ALPHA, S-TRANSFERASE-MU, AND S-TRANSFERASE-PI
Authors: CZWERWINSKI M GIBBS JP SLATTERY JT
Citation: M. Czwerwinski et al., BUSULFAN CONJUGATION BY GLUTATHIONE S-TRANSFERASE-ALPHA, S-TRANSFERASE-MU, AND S-TRANSFERASE-PI, Drug metabolism and disposition, 24(9), 1996, pp. 1015-1019
PROTEIN-REACTIVE METABOLITES OF CARBAMAZEPINE IN MOUSE-LIVER MICROSOMES
Authors: LILLIBRIDGE JH AMORE BM SLATTERY JT KALHORN TF NELSON SD FINNELL RH BENNETT GD
Citation: Jh. Lillibridge et al., PROTEIN-REACTIVE METABOLITES OF CARBAMAZEPINE IN MOUSE-LIVER MICROSOMES, Drug metabolism and disposition, 24(5), 1996, pp. 509-514
METABOLISM OF LISOFYLLINE AND PENTOXIFYLLINE IN HUMAN LIVER-MICROSOMES AND CYTOSOL
Authors: LILLIBRIDGE JA KALHORN TF SLATTERY JT
Citation: Ja. Lillibridge et al., METABOLISM OF LISOFYLLINE AND PENTOXIFYLLINE IN HUMAN LIVER-MICROSOMES AND CYTOSOL, Drug metabolism and disposition, 24(11), 1996, pp. 1174-1179
TERATOGENICITY OF CARBAMAZEPINE-10,11-EPOXIDE AND OXCARBAZEPINE IN THE SWV MOUSE
Authors: BENNETT GD AMORE BM FINNELL RH WLODARCZYK B KALHORN TF SKILES GL NELSON SD SLATTERY JT
Citation: Gd. Bennett et al., TERATOGENICITY OF CARBAMAZEPINE-10,11-EPOXIDE AND OXCARBAZEPINE IN THE SWV MOUSE, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1237-1242
EFFECTS OF CAFFEINE AND THEOPHYLLINE AN ACETAMINOPHEN PHARMACOKINETICS - P450 INHIBITION AND ACTIVATION
Authors: LEE CA LILLIBRIDGE JH NELSON SD SLATTERY JT
Citation: Ca. Lee et al., EFFECTS OF CAFFEINE AND THEOPHYLLINE AN ACETAMINOPHEN PHARMACOKINETICS - P450 INHIBITION AND ACTIVATION, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 287-291
THE COMPLEX INTERACTION BETWEEN ETHANOL AND ACETAMINOPHEN
Authors: SLATTERY JT NELSON SD THUMMEL KE
Citation: Jt. Slattery et al., THE COMPLEX INTERACTION BETWEEN ETHANOL AND ACETAMINOPHEN, Clinical pharmacology and therapeutics, 60(3), 1996, pp. 241-246
Risultati: 1-25 | 26-37